STANDARD BIOTOOLS INC. — insider transactions

1 transactions on record · LAB · CIK 1162194

Aggregates

computed from the filings below
Purchases, 12m
1
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
—
no sales recorded
Distinct insiders, 12m
1
Bought, 3m
$46.9K
Sold, 3m
$0
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$46.9K
2026-11-05
Director share, 12m
100.0%
of transactions where role is stated
Current run
1 buys
consecutive same-direction transactions
Net 3m flow
$46.9K
purchases minus sales
Total on record
1

Transactions

1 most recent shown
DisclosedRecorded (UTC)TradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-11-052026-11-06 03:17:44.816 UTC2026-11-050Carey Thomas D.DirectorOpen market purchase75,000$0.63$46.9Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR